Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Manor

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Cancer|July 1, 1994
B-cell malignancy after low grade T-cell lymphomaA Klein, Y Manor, S Abed, et al.
Cancer Genetics and Cytogenetics|August 5, 1999
Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridizationA Amiel, I Mulchanov, A Elis, et al.
American Journal of Hematology|December 12, 1997
Lymphoma with multi gene rearrangement on the level of immunoglobulin heavy chain, light chains, and T-cell receptor beta chainA Klein, R Zemer, Y Manor, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Deletion 5q31 in patients with stable, melphalan-treated multiple myelomaA Amiel, K Fridman, A Elis, et al.
Cancer Genetics and Cytogenetics|March 4, 2000
Multiple myeloma: monoallelic deletions of the tumor suppressor genes TP53 and RB1 in long-term follow-upM Carlebach, A Amiel, E Gaber, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Cancer Genetics and Cytogenetics|January 1, 1993
Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemiaA Amiel, S Yarkoni, M Fejgin, et al.
Cancer|October 22, 1998
Pleural effusion in patients with non-Hodgkin's lymphoma: a case-controlled studyA Elis, D Blickstein, I Mulchanov, et al.
Cancer Genetics and Cytogenetics|February 1, 1995
Fluorescence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia veraA Amiel, E Gaber, Y Manor, et al.
Vaccine|October 31, 1998
Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitisT A Swartz, R Handsher, Y Manor, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Cancer|July 1, 1994
B-cell malignancy after low grade T-cell lymphomaA Klein, Y Manor, S Abed, et al.
Cancer Genetics and Cytogenetics|August 5, 1999
Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridizationA Amiel, I Mulchanov, A Elis, et al.
American Journal of Hematology|December 12, 1997
Lymphoma with multi gene rearrangement on the level of immunoglobulin heavy chain, light chains, and T-cell receptor beta chainA Klein, R Zemer, Y Manor, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Deletion 5q31 in patients with stable, melphalan-treated multiple myelomaA Amiel, K Fridman, A Elis, et al.
Cancer Genetics and Cytogenetics|March 4, 2000
Multiple myeloma: monoallelic deletions of the tumor suppressor genes TP53 and RB1 in long-term follow-upM Carlebach, A Amiel, E Gaber, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Cancer Genetics and Cytogenetics|January 1, 1993
Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemiaA Amiel, S Yarkoni, M Fejgin, et al.
Cancer|October 22, 1998
Pleural effusion in patients with non-Hodgkin's lymphoma: a case-controlled studyA Elis, D Blickstein, I Mulchanov, et al.
Cancer Genetics and Cytogenetics|February 1, 1995
Fluorescence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia veraA Amiel, E Gaber, Y Manor, et al.
Vaccine|October 31, 1998
Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitisT A Swartz, R Handsher, Y Manor, et al.
Pageof 12